SEARCH

SEARCH BY CITATION

  • 1
    Huber PR, Schmid H-P, Mattarelli G, Strittmatter B, Van Steenbrugge GJ, Maurer A. Serum free prostate antigen. isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 1995; 27: 2129
  • 2
    Stone GR. Development of an Isoelectric Focusing Technique for the Separation and Identification of Serum PSA Isoenzymes. MSc Thesis. University of the West of England, UK, 1999
  • 3
    Reeves C, Martin J. Isoelectric focusing of serum psa isoforms in prostatic disease. Proceedings of the Pathology 2000 Meeting, Birmingham UK 2000: 110
  • 4
    Charrier J-P, Tournel C, Michel S, Dalbon P, Jolivet M. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia. Electrophoresis 1999; 20: 107581
  • 5
    Peter J, Unverzagt C, Krogh TN, Vorm O, Hoesel W. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry. Cancer Res 2001; 61: 95762
  • 6
    Nurmikko P, Pettersson K, Piironen T, Hugosson J, Lilja H. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. Clin Chem 2001; 47: 141523
  • 7
    Mikolajczyk SD, Millar LS, Wang TJ et al. ‘BPSA’, a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology 2000; 55: 415
  • 8
    Sokoll LJ, Chan DW, Mikolajczyk SD et al. Proenzyme PSA for the early detection of prostate cancer in the 2.5–4.0 ng/ml range: preliminary analysis. Urology 2003; 61: 2746
  • 9
    Mikolajczyk SD, Marks LS, Partin AW, Rittenhouse HG. Free prostate-specific antigen in serum is becoming more complex. Urology 2002; 59: 797802
  • 10
    Linton HJ, Marks LS, Millar LS, Knott CL, Rittenhouse HG, Mikolajczyk SD. Benign prostate- specific antigen (BPSA) in serum is increased in benign prostatic disease. Clin Chem 2003; 49: 2539